Σφακιανάκης Αλέξανδρος
ΩτοΡινοΛαρυγγολόγος
Αναπαύσεως 5 Άγιος Νικόλαος
Κρήτη 72100
00302841026182
00306932607174
alsfakia@gmail.com

Αρχειοθήκη ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader

Η λίστα ιστολογίων μου

Τετάρτη 1 Ιουνίου 2022

Symptom‐based remote assessment in post treatment head and neck cancer surveillance: a prospective national study

alexandrossfakianakis shared this article with you from Inoreader

Abstract

Objectives

To report the incidence of locoregional recurrence in HNC patients under surveillance following treatment undergoing symptom-based remote assessment.

Design

A 16-week multicentre prospective cohort study.

Setting

UK ENT departments.

Participants

HNC patients under surveillance following treatment undergoing symptom-based telephone assessment.

Main outcome measures

Incidence of locoregional recurrent HNC after minimum 6-month follow-up.

Results

Data for 1,078 cases were submitted by 16 centres, with follow-up data completed in 98.9% (n=1,066).

Following telephone consultation, 83.7% of referrals had their face-to-face appointments deferred (n=897/1,072). New symptoms were reported by 11.6% (n=124/1072) at telephone assessment; 72.6% (n=90/124) of this group were called for urgent assessments, of whom 48.9% (n=44/90) came directly for imaging without preceding clinical review.

The sensitivity and specificity for new symptoms as an indicator of cancer recurrence were 35.3% and 89.4%, respectively, with a negative predictive value of 99.7% (p=0.002).

Locoregional cancer identification rates after a minimum of 6 months of further monitoring, when correlated with time since treatment, were: 6.0% (n=14/233) <1 year; 2.1% (n=16/747) between 1 and 5 years; and 4.3% (n=4/92) for those >5 years since treatment.

Conclusions

Telephone assessment, using patient-reported symptoms, to identify recurrent locoregional HNC was widely adopted during the initial peak of the COVID-19 pandemic in the UK. The majority of patients had no face-to-face reviews or investigations. New symptoms were significantly associated with the identification of locoregional recurrent cancers with a high specificity, but a low sensitivity may limit symptom assessment being used as the sole surveillance method.

View on Web

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου